Nadia Nocera Zachariah, M.D., joins Miami Cancer Institute as Breast Surgical Oncologist
MIAMI – October 26th, 2021 – Board-certified breast surgical oncologist Nadia Nocera, M.D., joins Miami Cancer Institute, part of Baptist Health. Dr. Nocera specializes in treating breast cancer. She is fluent in English and conversational in Spanish and Italian.
“We are delighted to welcome Dr. Nocera to Miami Cancer Institute,” said Leonard Kalman, M.D., executive deputy director and chief medical officer at Miami Cancer Institute. “Her extensive fellowship training and research background will make her an outstanding addition to our team.”
Prior to joining Miami Cancer Institute, Dr. Nocera completed a fellowship in breast surgical oncology at the H. Lee Moffitt Cancer Center in Tampa.
She has been involved with dendritic cell vaccine research for breast cancer and melanoma. Her research has been published in peer-reviewed publications, including the Annals of Surgical Oncology, the Journal of Surgical Education, Immunotherapy and Frontiers in Pharmacology. She has also presented at numerous medical conferences, including the American Society of Breast Surgeons Annual Meeting and the Miami Breast Cancer Conference.
She is passionate about treating breast cancer because it allows her to develop lasting relationships with her patients by caring for them beyond their initial diagnosis. She also strives to provide patients with the most innovative and up-to-date care for their diagnosis.
Dr. Nocera earned her medical degree from New York Medical College. Her residency in general surgery was done at Hahnemann University Hospital/Drexel University College of Medicine and she completed her chief year of residency at Rowan University School of Osteopathic Medicine/Jefferson Health New Jersey. This was followed by her breast surgical oncology fellowship at the H. Lee Moffitt Cancer Center.
She will see patients at 1228 S. Pine Island Road, Suite 410, in Plantation.
About Baptist Health South Florida
Baptist Health South Florida is the largest healthcare organization in the region, with 11 hospitals, more than 23,000 employees, 4,000 physicians and 100 outpatient centers, urgent care facilities and physician practices spanning across Miami-Dade, Monroe, Broward and Palm Beach counties. Baptist Health has internationally renowned centers of excellence in cancer, cardiovascular care, orthopedics and sports medicine, and neurosciences. In addition, it includes Baptist Health Medical Group; Baptist Health Quality Network; and Baptist Health Care On Demand, a virtual health platform. A not-for-profit organization supported by philanthropy and committed to its faith-based charitable mission of medical excellence, Baptist Health has been recognized by Fortune as one of the 100 Best Companies to Work For in America and by Ethisphere as one of the World’s Most Ethical Companies. For more information, visit BaptistHealth.net/Newsroom and connect with us on Facebook, Instagram, Twitter and LinkedIn.
About Miami Cancer Institute
Miami Cancer Institute brings to South Florida access to personalized clinical treatments and comprehensive support services delivered with unparalleled compassion. No other cancer program in the region has the combination of cancer-fighting expertise and advanced technology—including the first proton therapy center in South Florida, Latin America and the Caribbean, and one of the only radiation oncology program in the world with each of the newest radiation therapies in one place—to diagnose and deliver precise cancer treatments that achieve the best outcomes and improve the lives of cancer patients. The Institute offers an impressive roster of established community oncologists and renowned experts, clinical researchers and genomic scientists recruited from the nation’s top cancer centers. Selected as Florida’s only member of the Memorial Sloan Kettering Cancer (MSK) Alliance, Miami Cancer Institute is part of a meaningful clinical collaboration that affords patients in South Florida access to innovative treatments and ensures that the standards of care developed by their multidisciplinary disease management teams match those at MSK.
# # #